Cover Image
Market Research Report
Product code 
1092318

Global Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Regional Outlook and Forecast, 2022 - 2028

Published: | KBV Research | 378 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Regional Outlook and Forecast, 2022 - 2028
Published: April 29, 2022
KBV Research
Content info: 378 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Global Sepsis Diagnostics Market size is expected to reach $879.5 million by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

Sepsis is a medical disorder that emerges as a result of the body's response to infections caused by bacteria, viruses, or fungus. The immune system produces various substances into the bloodstream in this situation, causing hyper inflammation and the production of blood clots. Multiple organ failures, rapid breathing, neurological dysfunction, low blood pressure, and a higher heart rate are all possible complications of sepsis. Molecular diagnosis, biomarkers, flow cytometry, immunoassays, microfluidics, and other processes are used to diagnose sepsis. Hospitals, pathology and reference laboratories, university academic researchers, and other institutions are all using these diagnostic tools.

In 2016, the Third International Sepsis Consensus Task Force determined the current criteria for clinical sepsis diagnosis, known as Sequential Organ Failure Assessment (SOFA). This scoring system detects cumulative organ dysfunction as a result of an infection-induced dysregulation of the host's immune system. Cardiovascular function, respiration, liver function, coagulation, central nervous system function, and renal function are all regarded in the SOFA score.

A point is given for each malfunctioning organ system, with a score of 2 points or higher indicating a definite sepsis diagnosis. A high SOFA score is linked to a higher than 10% hospital mortality risk. Quick SOFA (qSOFA) is a rapid alternative to SOFA that uses only a subset of the SOFA scoring criteria, such as abnormal mentation, systolic blood pressure under 100 mm Hg, and a breathing rate of 22 or more per minute. qSOFA does not necessitate laboratory testing and can be performed as many times as needed.

SOFA replaces the Systemic Inflammatory Response Syndrome (SIRS) criteria, which was created in 2001. SIRS scoring requires two or more of the following: a temperature of greater than 38°C or less than 36°C, a heart rate of greater than 90 beats per minute, a respiratory rate of greater than 20 beats per minute, or a white blood cell count of greater than 12,000/L or less than 4,000/L. When compared to SIRS and qSOFA, SOFA has higher predictive accuracy.

COVID-19 Impact

The COVID-19 pandemic had a marginally beneficial impact on sepsis diagnostics sales. The widespread of COVID-19 and the emergence of sepsis cases among COVID-19 patients are projected to boost the demand for quick diagnosis, speeding up the use of tools, reagents, and test kits for sepsis detection. COVID-19 infection is more likely to affect surgeons and patients undergoing a variety of procedures in hospitals. The bulk of sepsis diagnostics was halted, leading to a decrease in device-based treatments. People postponed health exams as a result of the pandemic's lockdowns, lowering the number of tests conducted and laboratory sales.

Market Growth Factors

A rise in the number of hospital-acquired illnesses

HAIs also characterized as nosocomial infections, a prominent cause of morbidity and mortality in hospitals across the world. The most common hospital-acquired illnesses include urinary tract infections, pneumonia, and sepsis (HAIs). HAIs can induce sepsis in immunocompromised people, the elderly, and people with medical conditions. According to the Centres for Disease Control and Prevention (CDC), sepsis affects at least 1.7 million adults in the United States each year, with about 270,000 deaths. An illness obtained at a medical facility, such as an inpatient setting or a skilled nursing care facility, is characterized as a healthcare-acquired infection (HAI). An HAI might come from anywhere, even a doctor's office or clinic. HAIs are known as nosocomial infections in the medical world. Infections acquired outside of a healthcare centre are known as community-acquired infections.

The rapidly growing Molecular Diagnostics market

Due to their ease of use and effectiveness in diagnostic procedures, molecular diagnostics has attracted a number of multinational companies and institutes. The gold standard for molecular diagnostic methods has been blood culture analysis for quick and precise infection profiling. Several firms are investing in point-of-care molecular diagnostics to improve patient management and early detection of bacterial and viral infections. For example, Immunexpress debuted a quick SeptiCyte, a one-hour molecular diagnostic test for sepsis, on Biocartis' Idylla platform in October 2020. This is one of the first completely integrated, immune response-based diagnostics to help clinicians diagnose sepsis.

Market Restraints Factors

High expense of automated diagnostic instruments

Companies are focusing on creating automated diagnostic instruments for identifying sepsis based on modern technologies such as molecular diagnostics. However, government hospitals and scientific research laboratories cannot acquire such systems due to budget constraints. Furthermore, it is becoming a key impediment to the expansion of the sepsis diagnostics market. In addition, the lowest intensity sepsis cohort population had the major burden of recurrence and total expenses. Sepsis cases that were not discovered until hospitalization, along with those with increasing severity, had a greater economic cost and death rate on a case-by-case basis.

Method Outlook

Based on Method, the market is segmented into Conventional and Automated. The automated segment witnessed a substantial revenue share in the Sepsis Diagnostics Market in 2021. The use of billing codes and the installation of predictable evaluation are based on agreement definitions that have been used in efforts to automate sepsis identification. Although billing codes are simple to extract and have a strong positive predictive value (PPV) for sepsis, they typically do not document the onset of sepsis and have low sensitivity when compared to clinician assessment. Changing medical practicing habits and reimbursement policies also have an impact on them. Consensus-based definitions have improved over time and across institutions, but they still rely on doctors to validate if organ dysfunction is attributable to sepsis, resulting in low PPV when automated.

Test Type Outlook

Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. The laboratory tests procured the highest revenue share in the Sepsis Diagnostics Market in 2021. This is mostly attributable to the fact that laboratory testing is more accurate than POC testing when it comes to identifying sepsis. Laboratory testing allows for a comprehensive examination of the pathogen and its medication resistance profile. In addition, routine lactate testing, which is a vague but valuable indication of sepsis, is done efficiently in laboratory settings. The public's and physicians' dependence on these labs has grown dramatically with the introduction of technologically advanced products.

Pathogen Outlook

Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. The fungal sepsis recorded a substantial revenue share in the Sepsis Diagnostics Market in 2021. Fungi are responsible for about 15% of all infections, and invasive fungal infections are becoming a more common cause of sepsis, especially in critically ill patients. This disease are life-threatening illness that can occur anywhere in the body as a result of an infection. Severe instances of sepsis are frequently caused by infections that spread throughout the body and through the bloodstream.

Product Outlook

Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. The software segment registered a substantial revenue share in the Sepsis Diagnostics Market in 2021. This rapid expansion of this segment can be ascribed to a rise in healthcare professionals' implementation of modern software platforms for better sepsis detection and management. For example, Guthrie, anintegrated health care system, used Wolters Kluwer's POC Advisor to diagnose and treat sepsis at four local hospitals in September 2019.

End-User Outlook

Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. The hospitals and specialty clinics segment procured the highest revenue share in the Sepsis Diagnostics Market in 2021. The rising number of patients diagnosed with sepsis, and in-house hospital and clinics are undertaking a large number of blood culture tests to identify blood stream infections (BSIs caused by bacteria, fungi/yeast, or viruses) contribute to the increased growth of this segment.

Technology Outlook

Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. The blood culture segment garnered the largest revenue share in the Sepsis Diagnostics Market in 2021. One of the most significant investigations in the treatment of sepsis is blood culture. It enables the identification of the sepsis-causing bacterium, the selection of a relevant empirical and specific antibiotic, and the identification of the infection's focal location. All sepsis patients should have a blood culture taken. Sepsis is traditionally described as the presence of infection-induced systemic inflammatory response syndrome (SIRS). Moreover, the affordable pricing of microbiological techniques and the widespread usage of blood culture procedures for sepsis diagnosis also account for this proportion.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The North America segment acquired the highest revenue share in the Sepsis Diagnostics Market in 2021. The medical device market in North America is well-established. The presence of a well-developed healthcare system, widespread implementation of innovative sepsis diagnosing technologies between health personnel, a reducing number of surgical procedures, growing prevalence of healthcare-associated infections (HAIs), and adoption of advanced technologies of sepsis diagnostics are all key factors that drive the sepsis diagnostics market in North America.

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the major forerunner in the Sepsis Diagnostics Market. Companies such as Thermo Fisher Scientific, Inc., Bruker Corporation and BioMerieux S.A. are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Recent strategies deployed in Sepsis Diagnostics Market

Partnerships, Collaborations and Agreements:

Jan-2022: Oncocyte Corporation signed a development and co-marketing agreement with Thermo Fisher Scientific, an American supplier of scientific instrumentation, reagents and consumables, and software services. This agreement aimed to distribute Vitro diagnostic evaluation on Thermo Fisher Scientific's Ion Torrent Genexus System. Additionally, Oncocyte would clinically approve Thermo Fisher's existing Oncomine complete Assay Plus on the Genexus System, paving the way toward IVD authorization for use in tumour mark and future resignation as a companion diagnostic.

Sep-2021: Thermo Fisher Scientific joined hands with AstraZeneca, a multinational pharmaceutical and biotechnology company. Together, the companies aimed to co-build NGS-based companion diagnostics to support AstraZeneca's expanding offering of address therapies. Additionally, Thermo Fisher would provide the expertise, technology, and capabilities to disperse CDx tests to local healthcare suppliers around our global markets, which would help in identifying more patients across the world who may asset from effective patient care and treatments.

Sep-2021: Siemens Healthineers joined hands with A1 Life Sciences, a pioneering biotechnology company. Together, the companies aimed to support global attempts to record variants of SARS-CoV-2, allowing Siemens Healthineers to provide a developing offering of PCR-based appraisal for the recognization of SARS-CoV-2 variants and mutations.

Apr-2021: DiaSorin came into a definitive merger agreement for DiaSorin to acquire Luminex Corporation. Under this acquisition DiaSorin would gain approach to Luminex's molecular diagnostics multiplexing technology and a offering that would reinforce its existing suite while expanding its presence in the U.S.

Mar-2021: Roche signed an agreement to acquire GenMark Diagnostics, a leading provider of multiplex molecular diagnostic solutions. Under the terms of the merger agreement, Roche would directly commence a tender provide to obtain all outstanding shares of GenMark's common stock. Additionally, GenMark would file a endorsement statement containing the united recommendation of the GenMark board that GenMark stockholders delicate shares to Roche.

Product Launches and Product Expansions:

Dec-2021: BD expanded the BD COR System by including a new MX instrument. This expansion aimed to assist proteomic molecular testing for contagious diseases. Additionally, the MX instrument is designed to prove BD MAX System molecular PCR technology platform, a medium-throughput system usually found in hospital labs, and BD aims to use the BD MAX System menu of contagious disease trail to generate assays that can be achieved in high-throughput central reference labs on the BD COR System

Jul-2020: Bruker Corporation introduced FluoroType SARS-CoV-2 along with next-generation 6-plex PCR. The medicine appraisal for the highly specific observation of the SARS-CoV-2 virus, which causes systemic and respiratory disease. Additionally, FluoroType SARS-CoV-2 plus estimation is CE-IVD characterised as per the European IVD Directive. Moreover, two clinical testings require almost ninety CV19 positive patients and over 100 CV19 negative individuals, this enhanced CV19 infection estimation showed 100% specificity and sensitivity.

Acquisitions and Merger:

Dec-2021: Thermo Fisher Scientific completed the acquisition of PPD, a global contract research organization. Under this acquisition, Thermo Fisher planned to deliver an entire offering of services around the clinical development spectrum, handling trial logistics, efficacy and healthcare outcome assessment, safety, comprising scientific discovery, along with the production and advancement of the therapeutics.

Dec-2021: Quidel Corporation completed the acquisition of Ortho Clinical Diagnostics Holdings, an in vitro diagnostics company. Under this acquisition, Ortho would assist concrete Quidel as a leader in the diagnostics companies, bringing together complementary products, innovative, services, and solutions that improve the health and well-being of patients around the world.

Sep-2021: Abbott took over Walk Vascular, a commercial-stage medical device enterprise. Through this acquisition, Walk Vascular would integrate within the vascular device portfolio and further propel Abbott's capabilities to deliver one-of-a-kind endovascular treatment solutions to enhance patient care.

Apr-2021: Siemens Healthineers took over Varian Medical Systems, an American radiation oncology treatments and software developer. With this acquisition, Siemens Healthineers has the most complete suite in the MedTech sector, which provides the enterprise with appreciable potential for value creation. Additionally, Siemens Healthineer's integrated approach would take the broad fight against cancer to a new level.

Jan-2021: Thermo Fisher Scientific completed the acquisition of Mesa Biotech, a molecular diagnostic company. Under this acquisition, Mesa Biotech's convenient quick PCR-based test would highly integral to the existing portfolio and would further assist to fulfil the constant demand for COVID-related checking while the company works to rapidly scale and advance point-of-care tests for other contagious diseases in the future.

Approvals and Trials:

Mar-2021: Thermo Fisher Scientific received FDA approval for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The PCR System would clarify abilities to workflow decrease steps to provide quality results in less than 30 minutes. Moreover, the PCR system has high sensitivity and precision as well as delivers up to six channels for multiplexing.

Sep-2020: Roche received FDA approval for Elecsys HIV Duo immunoassay. The approval enables a strong complete infectious diseases menu on the Cobas e 801 system and is a compelling step towards bringing integrative value to the U.S. market within the area of contagious diseases.

Scope of the Study

Market Segments covered in the Report:

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

By Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

By End-User

  • Hospitals & specialty clinics
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Technology

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • BioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Quidel Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Sepsis Diagnostics Market, by Method
    • 1.4.2 Global Sepsis Diagnostics Market, by Test Type
    • 1.4.3 Global Sepsis Diagnostics Market, by Pathogen
    • 1.4.4 Global Sepsis Diagnostics Market, by Product
    • 1.4.5 Global Sepsis Diagnostics Market, by End-User
    • 1.4.6 Global Sepsis Diagnostics Market, by Technology
    • 1.4.7 Global Sepsis Diagnostics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players

Chapter 4. Global Sepsis Diagnostics Market by Method

  • 4.1 Global Conventional Market by Region
  • 4.2 Global Automated Market by Region

Chapter 5. Global Sepsis Diagnostics Market by Test Type

  • 5.1 Global Laboratory Tests Market by Region
  • 5.2 Global Point-of-Care Tests Market by Region

Chapter 6. Global Sepsis Diagnostics Market by Pathogen

  • 6.1 Global Bacterial Sepsis Market by Region
  • 6.2 Global Fungal Sepsis Market by Region
  • 6.3 Global Viral Sepsis Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Sepsis Diagnostics Market by Product

  • 7.1 Global Blood Culture Media Market by Region
  • 7.2 Global Assays & Reagents Market by Region
  • 7.3 Global Instruments Market by Region
  • 7.4 Global Software Market by Region

Chapter 8. Global Sepsis Diagnostics Market by End-User

  • 8.1 Global Hospitals & specialty clinics Market by Region
  • 8.2 Global Pathology & Reference Laboratories Market by Region
  • 8.3 Global Research Laboratories & Academic Institutes Market by Region

Chapter 9. Global Sepsis Diagnostics Market by Technology

  • 9.1 Global Blood Culture Market by Region
  • 9.2 Global Immunoassays Market by Region
  • 9.3 Global Molecular Diagnostics Market by Region
  • 9.4 Global Flow Cytometry Market by Region
  • 9.5 Global Microfluidics Market by Region
  • 9.6 Global Biomarkers Market by Region

Chapter 10. Global Sepsis Diagnostics Market by Region

  • 10.1 North America Sepsis Diagnostics Market
    • 10.1.1 North America Sepsis Diagnostics Market by Method
      • 10.1.1.1 North America Conventional Market by Country
      • 10.1.1.2 North America Automated Market by Country
    • 10.1.2 North America Sepsis Diagnostics Market by Test Type
      • 10.1.2.1 North America Laboratory Tests Market by Country
      • 10.1.2.2 North America Point-of-Care Tests Market by Country
    • 10.1.3 North America Sepsis Diagnostics Market by Pathogen
      • 10.1.3.1 North America Bacterial Sepsis Market by Country
      • 10.1.3.2 North America Fungal Sepsis Market by Country
      • 10.1.3.3 North America Viral Sepsis Market by Country
      • 10.1.3.4 North America Others Market by Country
    • 10.1.4 North America Sepsis Diagnostics Market by Product
      • 10.1.4.1 North America Blood Culture Media Market by Country
      • 10.1.4.2 North America Assays & Reagents Market by Country
      • 10.1.4.3 North America Instruments Market by Country
      • 10.1.4.4 North America Software Market by Country
    • 10.1.5 North America Sepsis Diagnostics Market by End-User
      • 10.1.5.1 North America Hospitals & specialty clinics Market by Country
      • 10.1.5.2 North America Pathology & Reference Laboratories Market by Country
      • 10.1.5.3 North America Research Laboratories & Academic Institutes Market by Country
    • 10.1.6 North America Sepsis Diagnostics Market by Technology
      • 10.1.6.1 North America Blood Culture Market by Country
      • 10.1.6.2 North America Immunoassays Market by Country
      • 10.1.6.3 North America Molecular Diagnostics Market by Country
      • 10.1.6.4 North America Flow Cytometry Market by Country
      • 10.1.6.5 North America Microfluidics Market by Country
      • 10.1.6.6 North America Biomarkers Market by Country
    • 10.1.7 North America Sepsis Diagnostics Market by Country
      • 10.1.7.1 US Sepsis Diagnostics Market
        • 10.1.7.1.1 US Sepsis Diagnostics Market by Method
        • 10.1.7.1.2 US Sepsis Diagnostics Market by Test Type
        • 10.1.7.1.3 US Sepsis Diagnostics Market by Pathogen
        • 10.1.7.1.4 US Sepsis Diagnostics Market by Product
        • 10.1.7.1.5 US Sepsis Diagnostics Market by End-User
        • 10.1.7.1.6 US Sepsis Diagnostics Market by Technology
      • 10.1.7.2 Canada Sepsis Diagnostics Market
        • 10.1.7.2.1 Canada Sepsis Diagnostics Market by Method
        • 10.1.7.2.2 Canada Sepsis Diagnostics Market by Test Type
        • 10.1.7.2.3 Canada Sepsis Diagnostics Market by Pathogen
        • 10.1.7.2.4 Canada Sepsis Diagnostics Market by Product
        • 10.1.7.2.5 Canada Sepsis Diagnostics Market by End-User
        • 10.1.7.2.6 Canada Sepsis Diagnostics Market by Technology
      • 10.1.7.3 Mexico Sepsis Diagnostics Market
        • 10.1.7.3.1 Mexico Sepsis Diagnostics Market by Method
        • 10.1.7.3.2 Mexico Sepsis Diagnostics Market by Test Type
        • 10.1.7.3.3 Mexico Sepsis Diagnostics Market by Pathogen
        • 10.1.7.3.4 Mexico Sepsis Diagnostics Market by Product
        • 10.1.7.3.5 Mexico Sepsis Diagnostics Market by End-User
        • 10.1.7.3.6 Mexico Sepsis Diagnostics Market by Technology
      • 10.1.7.4 Rest of North America Sepsis Diagnostics Market
        • 10.1.7.4.1 Rest of North America Sepsis Diagnostics Market by Method
        • 10.1.7.4.2 Rest of North America Sepsis Diagnostics Market by Test Type
        • 10.1.7.4.3 Rest of North America Sepsis Diagnostics Market by Pathogen
        • 10.1.7.4.4 Rest of North America Sepsis Diagnostics Market by Product
        • 10.1.7.4.5 Rest of North America Sepsis Diagnostics Market by End-User
        • 10.1.7.4.6 Rest of North America Sepsis Diagnostics Market by Technology
  • 10.2 Europe Sepsis Diagnostics Market
    • 10.2.1 Europe Sepsis Diagnostics Market by Method
      • 10.2.1.1 Europe Conventional Market by Country
      • 10.2.1.2 Europe Automated Market by Country
    • 10.2.2 Europe Sepsis Diagnostics Market by Test Type
      • 10.2.2.1 Europe Laboratory Tests Market by Country
      • 10.2.2.2 Europe Point-of-Care Tests Market by Country
    • 10.2.3 Europe Sepsis Diagnostics Market by Pathogen
      • 10.2.3.1 Europe Bacterial Sepsis Market by Country
      • 10.2.3.2 Europe Fungal Sepsis Market by Country
      • 10.2.3.3 Europe Viral Sepsis Market by Country
      • 10.2.3.4 Europe Others Market by Country
    • 10.2.4 Europe Sepsis Diagnostics Market by Product
      • 10.2.4.1 Europe Blood Culture Media Market by Country
      • 10.2.4.2 Europe Assays & Reagents Market by Country
      • 10.2.4.3 Europe Instruments Market by Country
      • 10.2.4.4 Europe Software Market by Country
    • 10.2.5 Europe Sepsis Diagnostics Market by End-User
      • 10.2.5.1 Europe Hospitals & specialty clinics Market by Country
      • 10.2.5.2 Europe Pathology & Reference Laboratories Market by Country
      • 10.2.5.3 Europe Research Laboratories & Academic Institutes Market by Country
    • 10.2.6 Europe Sepsis Diagnostics Market by Technology
      • 10.2.6.1 Europe Blood Culture Market by Country
      • 10.2.6.2 Europe Immunoassays Market by Country
      • 10.2.6.3 Europe Molecular Diagnostics Market by Country
      • 10.2.6.4 Europe Flow Cytometry Market by Country
      • 10.2.6.5 Europe Microfluidics Market by Country
      • 10.2.6.6 Europe Biomarkers Market by Country
    • 10.2.7 Europe Sepsis Diagnostics Market by Country
      • 10.2.7.1 Germany Sepsis Diagnostics Market
        • 10.2.7.1.1 Germany Sepsis Diagnostics Market by Method
        • 10.2.7.1.2 Germany Sepsis Diagnostics Market by Test Type
        • 10.2.7.1.3 Germany Sepsis Diagnostics Market by Pathogen
        • 10.2.7.1.4 Germany Sepsis Diagnostics Market by Product
        • 10.2.7.1.5 Germany Sepsis Diagnostics Market by End-User
        • 10.2.7.1.6 Germany Sepsis Diagnostics Market by Technology
      • 10.2.7.2 UK Sepsis Diagnostics Market
        • 10.2.7.2.1 UK Sepsis Diagnostics Market by Method
        • 10.2.7.2.2 UK Sepsis Diagnostics Market by Test Type
        • 10.2.7.2.3 UK Sepsis Diagnostics Market by Pathogen
        • 10.2.7.2.4 UK Sepsis Diagnostics Market by Product
        • 10.2.7.2.5 UK Sepsis Diagnostics Market by End-User
        • 10.2.7.2.6 UK Sepsis Diagnostics Market by Technology
      • 10.2.7.3 France Sepsis Diagnostics Market
        • 10.2.7.3.1 France Sepsis Diagnostics Market by Method
        • 10.2.7.3.2 France Sepsis Diagnostics Market by Test Type
        • 10.2.7.3.3 France Sepsis Diagnostics Market by Pathogen
        • 10.2.7.3.4 France Sepsis Diagnostics Market by Product
        • 10.2.7.3.5 France Sepsis Diagnostics Market by End-User
        • 10.2.7.3.6 France Sepsis Diagnostics Market by Technology
      • 10.2.7.4 Russia Sepsis Diagnostics Market
        • 10.2.7.4.1 Russia Sepsis Diagnostics Market by Method
        • 10.2.7.4.2 Russia Sepsis Diagnostics Market by Test Type
        • 10.2.7.4.3 Russia Sepsis Diagnostics Market by Pathogen
        • 10.2.7.4.4 Russia Sepsis Diagnostics Market by Product
        • 10.2.7.4.5 Russia Sepsis Diagnostics Market by End-User
        • 10.2.7.4.6 Russia Sepsis Diagnostics Market by Technology
      • 10.2.7.5 Spain Sepsis Diagnostics Market
        • 10.2.7.5.1 Spain Sepsis Diagnostics Market by Method
        • 10.2.7.5.2 Spain Sepsis Diagnostics Market by Test Type
        • 10.2.7.5.3 Spain Sepsis Diagnostics Market by Pathogen
        • 10.2.7.5.4 Spain Sepsis Diagnostics Market by Product
        • 10.2.7.5.5 Spain Sepsis Diagnostics Market by End-User
        • 10.2.7.5.6 Spain Sepsis Diagnostics Market by Technology
      • 10.2.7.6 Italy Sepsis Diagnostics Market
        • 10.2.7.6.1 Italy Sepsis Diagnostics Market by Method
        • 10.2.7.6.2 Italy Sepsis Diagnostics Market by Test Type
        • 10.2.7.6.3 Italy Sepsis Diagnostics Market by Pathogen
        • 10.2.7.6.4 Italy Sepsis Diagnostics Market by Product
        • 10.2.7.6.5 Italy Sepsis Diagnostics Market by End-User
        • 10.2.7.6.6 Italy Sepsis Diagnostics Market by Technology
      • 10.2.7.7 Rest of Europe Sepsis Diagnostics Market
        • 10.2.7.7.1 Rest of Europe Sepsis Diagnostics Market by Method
        • 10.2.7.7.2 Rest of Europe Sepsis Diagnostics Market by Test Type
        • 10.2.7.7.3 Rest of Europe Sepsis Diagnostics Market by Pathogen
        • 10.2.7.7.4 Rest of Europe Sepsis Diagnostics Market by Product
        • 10.2.7.7.5 Rest of Europe Sepsis Diagnostics Market by End-User
        • 10.2.7.7.6 Rest of Europe Sepsis Diagnostics Market by Technology
  • 10.3 Asia Pacific Sepsis Diagnostics Market
    • 10.3.1 Asia Pacific Sepsis Diagnostics Market by Method
      • 10.3.1.1 Asia Pacific Conventional Market by Country
      • 10.3.1.2 Asia Pacific Automated Market by Country
    • 10.3.2 Asia Pacific Sepsis Diagnostics Market by Test Type
      • 10.3.2.1 Asia Pacific Laboratory Tests Market by Country
      • 10.3.2.2 Asia Pacific Point-of-Care Tests Market by Country
    • 10.3.3 Asia Pacific Sepsis Diagnostics Market by Pathogen
      • 10.3.3.1 Asia Pacific Bacterial Sepsis Market by Country
      • 10.3.3.2 Asia Pacific Fungal Sepsis Market by Country
      • 10.3.3.3 Asia Pacific Viral Sepsis Market by Country
      • 10.3.3.4 Asia Pacific Others Market by Country
    • 10.3.4 Asia Pacific Sepsis Diagnostics Market by Product
      • 10.3.4.1 Asia Pacific Blood Culture Media Market by Country
      • 10.3.4.2 Asia Pacific Assays & Reagents Market by Country
      • 10.3.4.3 Asia Pacific Instruments Market by Country
      • 10.3.4.4 Asia Pacific Software Market by Country
    • 10.3.5 Asia Pacific Sepsis Diagnostics Market by End-User
      • 10.3.5.1 Asia Pacific Hospitals & specialty clinics Market by Country
      • 10.3.5.2 Asia Pacific Pathology & Reference Laboratories Market by Country
      • 10.3.5.3 Asia Pacific Research Laboratories & Academic Institutes Market by Country
    • 10.3.6 Asia Pacific Sepsis Diagnostics Market by Technology
      • 10.3.6.1 Asia Pacific Blood Culture Market by Country
      • 10.3.6.2 Asia Pacific Immunoassays Market by Country
      • 10.3.6.3 Asia Pacific Molecular Diagnostics Market by Country
      • 10.3.6.4 Asia Pacific Flow Cytometry Market by Country
      • 10.3.6.5 Asia Pacific Microfluidics Market by Country
      • 10.3.6.6 Asia Pacific Biomarkers Market by Country
    • 10.3.7 Asia Pacific Sepsis Diagnostics Market by Country
      • 10.3.7.1 China Sepsis Diagnostics Market
        • 10.3.7.1.1 China Sepsis Diagnostics Market by Method
        • 10.3.7.1.2 China Sepsis Diagnostics Market by Test Type
        • 10.3.7.1.3 China Sepsis Diagnostics Market by Pathogen
        • 10.3.7.1.4 China Sepsis Diagnostics Market by Product
        • 10.3.7.1.5 China Sepsis Diagnostics Market by End-User
        • 10.3.7.1.6 China Sepsis Diagnostics Market by Technology
      • 10.3.7.2 Japan Sepsis Diagnostics Market
        • 10.3.7.2.1 Japan Sepsis Diagnostics Market by Method
        • 10.3.7.2.2 Japan Sepsis Diagnostics Market by Test Type
        • 10.3.7.2.3 Japan Sepsis Diagnostics Market by Pathogen
        • 10.3.7.2.4 Japan Sepsis Diagnostics Market by Product
        • 10.3.7.2.5 Japan Sepsis Diagnostics Market by End-User
        • 10.3.7.2.6 Japan Sepsis Diagnostics Market by Technology
      • 10.3.7.3 India Sepsis Diagnostics Market
        • 10.3.7.3.1 India Sepsis Diagnostics Market by Method
        • 10.3.7.3.2 India Sepsis Diagnostics Market by Test Type
        • 10.3.7.3.3 India Sepsis Diagnostics Market by Pathogen
        • 10.3.7.3.4 India Sepsis Diagnostics Market by Product
        • 10.3.7.3.5 India Sepsis Diagnostics Market by End-User
        • 10.3.7.3.6 India Sepsis Diagnostics Market by Technology
      • 10.3.7.4 South Korea Sepsis Diagnostics Market
        • 10.3.7.4.1 South Korea Sepsis Diagnostics Market by Method
        • 10.3.7.4.2 South Korea Sepsis Diagnostics Market by Test Type
        • 10.3.7.4.3 South Korea Sepsis Diagnostics Market by Pathogen
        • 10.3.7.4.4 South Korea Sepsis Diagnostics Market by Product
        • 10.3.7.4.5 South Korea Sepsis Diagnostics Market by End-User
        • 10.3.7.4.6 South Korea Sepsis Diagnostics Market by Technology
      • 10.3.7.5 Singapore Sepsis Diagnostics Market
        • 10.3.7.5.1 Singapore Sepsis Diagnostics Market by Method
        • 10.3.7.5.2 Singapore Sepsis Diagnostics Market by Test Type
        • 10.3.7.5.3 Singapore Sepsis Diagnostics Market by Pathogen
        • 10.3.7.5.4 Singapore Sepsis Diagnostics Market by Product
        • 10.3.7.5.5 Singapore Sepsis Diagnostics Market by End-User
        • 10.3.7.5.6 Singapore Sepsis Diagnostics Market by Technology
      • 10.3.7.6 Malaysia Sepsis Diagnostics Market
        • 10.3.7.6.1 Malaysia Sepsis Diagnostics Market by Method
        • 10.3.7.6.2 Malaysia Sepsis Diagnostics Market by Test Type
        • 10.3.7.6.3 Malaysia Sepsis Diagnostics Market by Pathogen
        • 10.3.7.6.4 Malaysia Sepsis Diagnostics Market by Product
        • 10.3.7.6.5 Malaysia Sepsis Diagnostics Market by End-User
        • 10.3.7.6.6 Malaysia Sepsis Diagnostics Market by Technology
      • 10.3.7.7 Rest of Asia Pacific Sepsis Diagnostics Market
        • 10.3.7.7.1 Rest of Asia Pacific Sepsis Diagnostics Market
        • 10.3.7.7.2 Rest of Asia Pacific Sepsis Diagnostics Market by Method
        • 10.3.7.7.3 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type
        • 10.3.7.7.4 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen
        • 10.3.7.7.5 Rest of Asia Pacific Sepsis Diagnostics Market by Product
        • 10.3.7.7.6 Rest of Asia Pacific Sepsis Diagnostics Market by End-User
        • 10.3.7.7.7 Rest of Asia Pacific Sepsis Diagnostics Market by Technology
  • 10.4 LAMEA Sepsis Diagnostics Market
    • 10.4.1 LAMEA Sepsis Diagnostics Market by Method
      • 10.4.1.1 LAMEA Conventional Market by Country
      • 10.4.1.2 LAMEA Automated Market by Country
    • 10.4.2 LAMEA Sepsis Diagnostics Market by Test Type
      • 10.4.2.1 LAMEA Laboratory Tests Market by Country
      • 10.4.2.2 LAMEA Point-of-Care Tests Market by Country
    • 10.4.3 LAMEA Sepsis Diagnostics Market by Pathogen
      • 10.4.3.1 LAMEA Bacterial Sepsis Market by Country
      • 10.4.3.2 LAMEA Fungal Sepsis Market by Country
      • 10.4.3.3 LAMEA Viral Sepsis Market by Country
      • 10.4.3.4 LAMEA Others Market by Country
    • 10.4.4 LAMEA Sepsis Diagnostics Market by Product
      • 10.4.4.1 LAMEA Blood Culture Media Market by Country
      • 10.4.4.2 LAMEA Assays & Reagents Market by Country
      • 10.4.4.3 LAMEA Instruments Market by Country
      • 10.4.4.4 LAMEA Software Market by Country
    • 10.4.5 LAMEA Sepsis Diagnostics Market by End-User
      • 10.4.5.1 LAMEA Hospitals & specialty clinics Market by Country
      • 10.4.5.2 LAMEA Pathology & Reference Laboratories Market by Country
      • 10.4.5.3 LAMEA Research Laboratories & Academic Institutes Market by Country
    • 10.4.6 LAMEA Sepsis Diagnostics Market by Technology
      • 10.4.6.1 LAMEA Blood Culture Market by Country
      • 10.4.6.2 LAMEA Immunoassays Market by Country
      • 10.4.6.3 LAMEA Molecular Diagnostics Market by Country
      • 10.4.6.4 LAMEA Flow Cytometry Market by Country
      • 10.4.6.5 LAMEA Microfluidics Market by Country
      • 10.4.6.6 LAMEA Biomarkers Market by Country
    • 10.4.7 LAMEA Sepsis Diagnostics Market by Country
      • 10.4.7.1 Brazil Sepsis Diagnostics Market
        • 10.4.7.1.1 Brazil Sepsis Diagnostics Market by Method
        • 10.4.7.1.2 Brazil Sepsis Diagnostics Market by Test Type
        • 10.4.7.1.3 Brazil Sepsis Diagnostics Market by Pathogen
        • 10.4.7.1.4 Brazil Sepsis Diagnostics Market by Product
        • 10.4.7.1.5 Brazil Sepsis Diagnostics Market by End-User
        • 10.4.7.1.6 Brazil Sepsis Diagnostics Market by Technology
      • 10.4.7.2 Argentina Sepsis Diagnostics Market
        • 10.4.7.2.1 Argentina Sepsis Diagnostics Market by Method
        • 10.4.7.2.2 Argentina Sepsis Diagnostics Market by Test Type
        • 10.4.7.2.3 Argentina Sepsis Diagnostics Market by Pathogen
        • 10.4.7.2.4 Argentina Sepsis Diagnostics Market by Product
        • 10.4.7.2.5 Argentina Sepsis Diagnostics Market by End-User
        • 10.4.7.2.6 Argentina Sepsis Diagnostics Market by Technology
      • 10.4.7.3 UAE Sepsis Diagnostics Market
        • 10.4.7.3.1 UAE Sepsis Diagnostics Market by Method
        • 10.4.7.3.2 UAE Sepsis Diagnostics Market by Test Type
        • 10.4.7.3.3 UAE Sepsis Diagnostics Market by Pathogen
        • 10.4.7.3.4 UAE Sepsis Diagnostics Market by Product
        • 10.4.7.3.5 UAE Sepsis Diagnostics Market by End-User
        • 10.4.7.3.6 UAE Sepsis Diagnostics Market by Technology
      • 10.4.7.4 Saudi Arabia Sepsis Diagnostics Market
        • 10.4.7.4.1 Saudi Arabia Sepsis Diagnostics Market by Method
        • 10.4.7.4.2 Saudi Arabia Sepsis Diagnostics Market by Test Type
        • 10.4.7.4.3 Saudi Arabia Sepsis Diagnostics Market by Pathogen
        • 10.4.7.4.4 Saudi Arabia Sepsis Diagnostics Market by Product
        • 10.4.7.4.5 Saudi Arabia Sepsis Diagnostics Market by End-User
        • 10.4.7.4.6 Saudi Arabia Sepsis Diagnostics Market by Technology
      • 10.4.7.5 South Africa Sepsis Diagnostics Market
        • 10.4.7.5.1 South Africa Sepsis Diagnostics Market by Method
        • 10.4.7.5.2 South Africa Sepsis Diagnostics Market by Test Type
        • 10.4.7.5.3 South Africa Sepsis Diagnostics Market by Pathogen
        • 10.4.7.5.4 South Africa Sepsis Diagnostics Market by Product
        • 10.4.7.5.5 South Africa Sepsis Diagnostics Market by End-User
        • 10.4.7.5.6 South Africa Sepsis Diagnostics Market by Technology
      • 10.4.7.6 Nigeria Sepsis Diagnostics Market
        • 10.4.7.6.1 Nigeria Sepsis Diagnostics Market by Method
        • 10.4.7.6.2 Nigeria Sepsis Diagnostics Market by Test Type
        • 10.4.7.6.3 Nigeria Sepsis Diagnostics Market by Pathogen
        • 10.4.7.6.4 Nigeria Sepsis Diagnostics Market by Product
        • 10.4.7.6.5 Nigeria Sepsis Diagnostics Market by End-User
        • 10.4.7.6.6 Nigeria Sepsis Diagnostics Market by Technology
      • 10.4.7.7 Rest of LAMEA Sepsis Diagnostics Market
        • 10.4.7.7.1 Rest of LAMEA Sepsis Diagnostics Market by Method
        • 10.4.7.7.2 Rest of LAMEA Sepsis Diagnostics Market by Test Type
        • 10.4.7.7.3 Rest of LAMEA Sepsis Diagnostics Market by Pathogen
        • 10.4.7.7.4 Rest of LAMEA Sepsis Diagnostics Market by Product
        • 10.4.7.7.5 Rest of LAMEA Sepsis Diagnostics Market by End-User
        • 10.4.7.7.6 Rest of LAMEA Sepsis Diagnostics Market by Technology

Chapter 11. Company Profiles

  • 11.1 BioMerieux S.A.
    • 11.1.1 Company Overview
    • 11.1.2 Financial Analysis
    • 11.1.3 Segmental and Regional Analysis
    • 11.1.4 Research & Development Expenses
    • 11.1.5 Recent strategies and developments:
      • 11.1.5.1 Acquisition and Mergers:
  • 11.2 F. Hoffmann-La Roche Ltd.
    • 11.2.1 Company Overview
    • 11.2.2 Financial Analysis
    • 11.2.3 Segmental and Regional Analysis
    • 11.2.4 Research & Development Expense
    • 11.2.5 Recent strategies and developments:
      • 11.2.5.1 Partnerships, Collaborations, and Agreements:
      • 11.2.5.2 Approvals and Trials:
  • 11.3 Becton, Dickinson and Company
    • 11.3.1 Company Overview
    • 11.3.2 Financial Analysis
    • 11.3.3 Segmental and Regional Analysis
    • 11.3.4 Research & Development Expense
    • 11.3.5 Recent strategies and developments:
      • 11.3.5.1 Product Launches and Product Expansions:
  • 11.4 Abbott Laboratories
    • 11.4.1 Company Overview
    • 11.4.2 Financial Analysis
    • 11.4.3 Segmental and Regional Analysis
    • 11.4.4 Research & Development Expense
    • 11.4.5 Recent strategies and developments:
      • 11.4.5.1 Acquisition and Mergers:
  • 11.5 Thermo Fisher Scientific, Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Analysis
    • 11.5.3 Segmental and Regional Analysis
    • 11.5.4 Research & Development Expense
    • 11.5.5 Recent strategies and developments:
      • 11.5.5.1 Partnerships, Collaborations, and Agreements:
      • 11.5.5.2 Approvals and Trials:
      • 11.5.5.3 Acquisition and Mergers:
    • 11.5.6 SWOT Analysis
  • 11.6 DiaSorin S.p.A. (Luminex Corporation)
    • 11.6.1 Company Overview
    • 11.6.2 Financial Analysis
    • 11.6.3 Regional Analysis
    • 11.6.4 Research & Development Expenses
    • 11.6.5 Recent strategies and developments:
      • 11.6.5.1 Acquisitions and Mergers:
  • 11.7 Bruker Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Financial Analysis
    • 11.7.3 Segmental and Regional Analysis
    • 11.7.4 Research & Development Expense
    • 11.7.5 Recent strategies and developments:
      • 11.7.5.1 Product Launches and Product Expansions:
      • 11.7.5.2 Acquisition and Mergers:
  • 11.8 Siemens Healthineers AG (Siemens AG)
    • 11.8.1 Company Overview
    • 11.8.2 Financial Analysis
    • 11.8.3 Segmental and Regional Analysis
    • 11.8.4 Research & Development Expenses
    • 11.8.5 Recent strategies and developments:
      • 11.8.5.1 Partnerships, Collaborations, and Agreements:
      • 11.8.5.2 Acquisition and Mergers:
  • 11.9 Danaher Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Financial Analysis
    • 11.9.3 Segmental and Regional Analysis
    • 11.9.4 Research & Development Expense
  • 11.10. Quidel Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Financial Analysis
    • 11.10.3 Regional Analysis
    • 11.10.4 Research & Development Expense
    • 11.10.5 Recent strategies and developments:
      • 11.10.5.1 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 Global Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Sepsis Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions - Sepsis Diagnostics Market
  • TABLE 5 Acquisition and Mergers - Sepsis Diagnostics Market
  • TABLE 6 Approvals and Trials - Sepsis Diagnostics Market
  • TABLE 7 Global Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 8 Global Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 9 Global Conventional Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Conventional Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Automated Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Automated Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 14 Global Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 15 Global Laboratory Tests Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Laboratory Tests Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Point-of-Care Tests Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Point-of-Care Tests Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 20 Global Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 21 Global Bacterial Sepsis Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Bacterial Sepsis Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Fungal Sepsis Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Fungal Sepsis Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Viral Sepsis Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Viral Sepsis Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 30 Global Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 31 Global Blood Culture Media Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Blood Culture Media Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Assays & Reagents Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Assays & Reagents Market by Region, 2022 - 2028, USD Million
  • TABLE 35 Global Instruments Market by Region, 2018 - 2021, USD Million
  • TABLE 36 Global Instruments Market by Region, 2022 - 2028, USD Million
  • TABLE 37 Global Software Market by Region, 2018 - 2021, USD Million
  • TABLE 38 Global Software Market by Region, 2022 - 2028, USD Million
  • TABLE 39 Global Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 40 Global Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 41 Global Hospitals & specialty clinics Market by Region, 2018 - 2021, USD Million
  • TABLE 42 Global Hospitals & specialty clinics Market by Region, 2022 - 2028, USD Million
  • TABLE 43 Global Pathology & Reference Laboratories Market by Region, 2018 - 2021, USD Million
  • TABLE 44 Global Pathology & Reference Laboratories Market by Region, 2022 - 2028, USD Million
  • TABLE 45 Global Research Laboratories & Academic Institutes Market by Region, 2018 - 2021, USD Million
  • TABLE 46 Global Research Laboratories & Academic Institutes Market by Region, 2022 - 2028, USD Million
  • TABLE 47 Global Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 48 Global Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 49 Global Blood Culture Market by Region, 2018 - 2021, USD Million
  • TABLE 50 Global Blood Culture Market by Region, 2022 - 2028, USD Million
  • TABLE 51 Global Immunoassays Market by Region, 2018 - 2021, USD Million
  • TABLE 52 Global Immunoassays Market by Region, 2022 - 2028, USD Million
  • TABLE 53 Global Molecular Diagnostics Market by Region, 2018 - 2021, USD Million
  • TABLE 54 Global Molecular Diagnostics Market by Region, 2022 - 2028, USD Million
  • TABLE 55 Global Flow Cytometry Market by Region, 2018 - 2021, USD Million
  • TABLE 56 Global Flow Cytometry Market by Region, 2022 - 2028, USD Million
  • TABLE 57 Global Microfluidics Market by Region, 2018 - 2021, USD Million
  • TABLE 58 Global Microfluidics Market by Region, 2022 - 2028, USD Million
  • TABLE 59 Global Biomarkers Market by Region, 2018 - 2021, USD Million
  • TABLE 60 Global Biomarkers Market by Region, 2022 - 2028, USD Million
  • TABLE 61 Global Sepsis Diagnostics Market by Region, 2018 - 2021, USD Million
  • TABLE 62 Global Sepsis Diagnostics Market by Region, 2022 - 2028, USD Million
  • TABLE 63 North America Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 64 North America Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 65 North America Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 66 North America Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 67 North America Conventional Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Conventional Market by Country, 2022 - 2028, USD Million
  • TABLE 69 North America Automated Market by Country, 2018 - 2021, USD Million
  • TABLE 70 North America Automated Market by Country, 2022 - 2028, USD Million
  • TABLE 71 North America Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 72 North America Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 73 North America Laboratory Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 74 North America Laboratory Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 75 North America Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 76 North America Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 77 North America Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 78 North America Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 79 North America Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 80 North America Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 81 North America Fungal Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 82 North America Fungal Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 83 North America Viral Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 84 North America Viral Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 85 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 86 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 87 North America Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 88 North America Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 89 North America Blood Culture Media Market by Country, 2018 - 2021, USD Million
  • TABLE 90 North America Blood Culture Media Market by Country, 2022 - 2028, USD Million
  • TABLE 91 North America Assays & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 92 North America Assays & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 93 North America Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 94 North America Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 95 North America Software Market by Country, 2018 - 2021, USD Million
  • TABLE 96 North America Software Market by Country, 2022 - 2028, USD Million
  • TABLE 97 North America Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 98 North America Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 99 North America Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 100 North America Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 101 North America Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 102 North America Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 103 North America Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 104 North America Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 105 North America Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 106 North America Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 107 North America Blood Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 108 North America Blood Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 109 North America Immunoassays Market by Country, 2018 - 2021, USD Million
  • TABLE 110 North America Immunoassays Market by Country, 2022 - 2028, USD Million
  • TABLE 111 North America Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 112 North America Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 113 North America Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 114 North America Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 115 North America Microfluidics Market by Country, 2018 - 2021, USD Million
  • TABLE 116 North America Microfluidics Market by Country, 2022 - 2028, USD Million
  • TABLE 117 North America Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 118 North America Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 119 North America Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 120 North America Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 121 US Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 122 US Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 123 US Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 124 US Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 125 US Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 126 US Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 127 US Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 128 US Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 129 US Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 130 US Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 131 US Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 132 US Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 133 US Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 134 US Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 135 Canada Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 136 Canada Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 137 Canada Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 138 Canada Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 139 Canada Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 140 Canada Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 141 Canada Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 142 Canada Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 143 Canada Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 144 Canada Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 145 Canada Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 146 Canada Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 147 Canada Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 148 Canada Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 149 Mexico Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 150 Mexico Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 151 Mexico Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 152 Mexico Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 153 Mexico Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 154 Mexico Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 155 Mexico Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 156 Mexico Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 157 Mexico Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 158 Mexico Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 159 Mexico Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 160 Mexico Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 161 Mexico Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 162 Mexico Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 163 Rest of North America Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 164 Rest of North America Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 165 Rest of North America Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 166 Rest of North America Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 167 Rest of North America Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 168 Rest of North America Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 169 Rest of North America Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 170 Rest of North America Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 171 Rest of North America Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 172 Rest of North America Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 173 Rest of North America Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 174 Rest of North America Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 175 Rest of North America Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 176 Rest of North America Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 177 Europe Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 178 Europe Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 179 Europe Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 180 Europe Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 181 Europe Conventional Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Europe Conventional Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Europe Automated Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Europe Automated Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Europe Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 186 Europe Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 187 Europe Laboratory Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Europe Laboratory Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Europe Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Europe Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Europe Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 192 Europe Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 193 Europe Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Europe Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Europe Fungal Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Europe Fungal Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Europe Viral Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Europe Viral Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Europe Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 202 Europe Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 203 Europe Blood Culture Media Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Europe Blood Culture Media Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Europe Assays & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Europe Assays & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Europe Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Europe Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Europe Software Market by Country, 2018 - 2021, USD Million
  • TABLE 210 Europe Software Market by Country, 2022 - 2028, USD Million
  • TABLE 211 Europe Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 212 Europe Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 213 Europe Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 214 Europe Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 215 Europe Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 216 Europe Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 217 Europe Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 218 Europe Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 219 Europe Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 220 Europe Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 221 Europe Blood Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 222 Europe Blood Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 223 Europe Immunoassays Market by Country, 2018 - 2021, USD Million
  • TABLE 224 Europe Immunoassays Market by Country, 2022 - 2028, USD Million
  • TABLE 225 Europe Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 226 Europe Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 227 Europe Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 228 Europe Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 229 Europe Microfluidics Market by Country, 2018 - 2021, USD Million
  • TABLE 230 Europe Microfluidics Market by Country, 2022 - 2028, USD Million
  • TABLE 231 Europe Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 232 Europe Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 233 Europe Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 234 Europe Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 235 Germany Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 236 Germany Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 237 Germany Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 238 Germany Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 239 Germany Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 240 Germany Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 241 Germany Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 242 Germany Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 243 Germany Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 244 Germany Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 245 Germany Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 246 Germany Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 247 Germany Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 248 Germany Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 249 UK Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 250 UK Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 251 UK Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 252 UK Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 253 UK Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 254 UK Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 255 UK Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 256 UK Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 257 UK Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 258 UK Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 259 UK Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 260 UK Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 261 UK Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 262 UK Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 263 France Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 264 France Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 265 France Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 266 France Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 267 France Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 268 France Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 269 France Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 270 France Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 271 France Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 272 France Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 273 France Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 274 France Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 275 France Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 276 France Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 277 Russia Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 278 Russia Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 279 Russia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 280 Russia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 281 Russia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 282 Russia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 283 Russia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 284 Russia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 285 Russia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 286 Russia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 287 Russia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 288 Russia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 289 Russia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 290 Russia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 291 Spain Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 292 Spain Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 293 Spain Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 294 Spain Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 295 Spain Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 296 Spain Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 297 Spain Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 298 Spain Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 299 Spain Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 300 Spain Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 301 Spain Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 302 Spain Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 303 Spain Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 304 Spain Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 305 Italy Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 306 Italy Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 307 Italy Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 308 Italy Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 309 Italy Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 310 Italy Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 311 Italy Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 312 Italy Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 313 Italy Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 314 Italy Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 315 Italy Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 316 Italy Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 317 Italy Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 318 Italy Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 319 Rest of Europe Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 320 Rest of Europe Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 321 Rest of Europe Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 322 Rest of Europe Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 323 Rest of Europe Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 324 Rest of Europe Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 325 Rest of Europe Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 326 Rest of Europe Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 327 Rest of Europe Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 328 Rest of Europe Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 329 Rest of Europe Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 330 Rest of Europe Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 331 Rest of Europe Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 332 Rest of Europe Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 333 Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 334 Asia Pacific Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 335 Asia Pacific Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 336 Asia Pacific Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 337 Asia Pacific Conventional Market by Country, 2018 - 2021, USD Million
  • TABLE 338 Asia Pacific Conventional Market by Country, 2022 - 2028, USD Million
  • TABLE 339 Asia Pacific Automated Market by Country, 2018 - 2021, USD Million
  • TABLE 340 Asia Pacific Automated Market by Country, 2022 - 2028, USD Million
  • TABLE 341 Asia Pacific Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 342 Asia Pacific Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 343 Asia Pacific Laboratory Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 344 Asia Pacific Laboratory Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 345 Asia Pacific Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 346 Asia Pacific Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 347 Asia Pacific Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 348 Asia Pacific Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 349 Asia Pacific Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 350 Asia Pacific Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 351 Asia Pacific Fungal Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 352 Asia Pacific Fungal Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 353 Asia Pacific Viral Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 354 Asia Pacific Viral Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 355 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 356 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 357 Asia Pacific Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 358 Asia Pacific Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 359 Asia Pacific Blood Culture Media Market by Country, 2018 - 2021, USD Million
  • TABLE 360 Asia Pacific Blood Culture Media Market by Country, 2022 - 2028, USD Million
  • TABLE 361 Asia Pacific Assays & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 362 Asia Pacific Assays & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 363 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 364 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 365 Asia Pacific Software Market by Country, 2018 - 2021, USD Million
  • TABLE 366 Asia Pacific Software Market by Country, 2022 - 2028, USD Million
  • TABLE 367 Asia Pacific Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 368 Asia Pacific Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 369 Asia Pacific Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 370 Asia Pacific Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 371 Asia Pacific Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 372 Asia Pacific Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 373 Asia Pacific Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 374 Asia Pacific Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 375 Asia Pacific Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 376 Asia Pacific Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 377 Asia Pacific Blood Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 378 Asia Pacific Blood Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 379 Asia Pacific Immunoassays Market by Country, 2018 - 2021, USD Million
  • TABLE 380 Asia Pacific Immunoassays Market by Country, 2022 - 2028, USD Million
  • TABLE 381 Asia Pacific Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 382 Asia Pacific Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 383 Asia Pacific Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 384 Asia Pacific Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 385 Asia Pacific Microfluidics Market by Country, 2018 - 2021, USD Million
  • TABLE 386 Asia Pacific Microfluidics Market by Country, 2022 - 2028, USD Million
  • TABLE 387 Asia Pacific Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 388 Asia Pacific Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 389 Asia Pacific Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 390 Asia Pacific Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 391 China Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 392 China Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 393 China Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 394 China Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 395 China Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 396 China Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 397 China Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 398 China Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 399 China Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 400 China Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 401 China Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 402 China Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 403 China Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 404 China Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 405 Japan Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 406 Japan Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 407 Japan Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 408 Japan Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 409 Japan Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 410 Japan Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 411 Japan Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 412 Japan Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 413 Japan Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 414 Japan Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 415 Japan Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 416 Japan Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 417 Japan Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 418 Japan Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 419 India Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 420 India Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 421 India Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 422 India Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 423 India Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 424 India Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 425 India Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 426 India Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 427 India Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 428 India Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 429 India Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 430 India Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 431 India Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 432 India Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 433 South Korea Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 434 South Korea Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 435 South Korea Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 436 South Korea Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 437 South Korea Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 438 South Korea Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 439 South Korea Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 440 South Korea Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 441 South Korea Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 442 South Korea Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 443 South Korea Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 444 South Korea Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 445 South Korea Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 446 South Korea Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 447 Singapore Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 448 Singapore Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 449 Singapore Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 450 Singapore Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 451 Singapore Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 452 Singapore Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 453 Singapore Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 454 Singapore Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 455 Singapore Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 456 Singapore Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 457 Singapore Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 458 Singapore Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 459 Singapore Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 460 Singapore Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 461 Malaysia Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 462 Malaysia Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 463 Malaysia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 464 Malaysia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 465 Malaysia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 466 Malaysia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 467 Malaysia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 468 Malaysia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 469 Malaysia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 470 Malaysia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 471 Malaysia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 472 Malaysia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 473 Malaysia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 474 Malaysia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 475 Rest of Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 476 Rest of Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 477 Rest of Asia Pacific Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 478 Rest of Asia Pacific Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 479 Rest of Asia Pacific Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 480 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 481 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 482 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 483 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 484 Rest of Asia Pacific Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 485 Rest of Asia Pacific Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 486 Rest of Asia Pacific Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 487 Rest of Asia Pacific Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 488 Rest of Asia Pacific Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 489 Rest of Asia Pacific Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 490 LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 491 LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 492 LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 493 LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 494 LAMEA Conventional Market by Country, 2018 - 2021, USD Million
  • TABLE 495 LAMEA Conventional Market by Country, 2022 - 2028, USD Million
  • TABLE 496 LAMEA Automated Market by Country, 2018 - 2021, USD Million
  • TABLE 497 LAMEA Automated Market by Country, 2022 - 2028, USD Million
  • TABLE 498 LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 499 LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 500 LAMEA Laboratory Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 501 LAMEA Laboratory Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 502 LAMEA Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 503 LAMEA Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 504 LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 505 LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 506 LAMEA Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 507 LAMEA Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 508 LAMEA Fungal Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 509 LAMEA Fungal Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 510 LAMEA Viral Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 511 LAMEA Viral Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 512 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 513 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 514 LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 515 LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 516 LAMEA Blood Culture Media Market by Country, 2018 - 2021, USD Million
  • TABLE 517 LAMEA Blood Culture Media Market by Country, 2022 - 2028, USD Million
  • TABLE 518 LAMEA Assays & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 519 LAMEA Assays & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 520 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 521 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 522 LAMEA Software Market by Country, 2018 - 2021, USD Million
  • TABLE 523 LAMEA Software Market by Country, 2022 - 2028, USD Million
  • TABLE 524 LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 525 LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 526 LAMEA Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 527 LAMEA Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 528 LAMEA Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 529 LAMEA Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 530 LAMEA Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 531 LAMEA Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 532 LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 533 LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 534 LAMEA Blood Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 535 LAMEA Blood Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 536 LAMEA Immunoassays Market by Country, 2018 - 2021, USD Million
  • TABLE 537 LAMEA Immunoassays Market by Country, 2022 - 2028, USD Million
  • TABLE 538 LAMEA Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 539 LAMEA Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 540 LAMEA Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 541 LAMEA Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 542 LAMEA Microfluidics Market by Country, 2018 - 2021, USD Million
  • TABLE 543 LAMEA Microfluidics Market by Country, 2022 - 2028, USD Million
  • TABLE 544 LAMEA Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 545 LAMEA Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 546 LAMEA Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 547 LAMEA Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 548 Brazil Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 549 Brazil Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 550 Brazil Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 551 Brazil Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 552 Brazil Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 553 Brazil Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 554 Brazil Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 555 Brazil Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 556 Brazil Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 557 Brazil Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 558 Brazil Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 559 Brazil Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 560 Brazil Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 561 Brazil Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 562 Argentina Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 563 Argentina Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 564 Argentina Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 565 Argentina Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 566 Argentina Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 567 Argentina Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 568 Argentina Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 569 Argentina Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 570 Argentina Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 571 Argentina Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 572 Argentina Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 573 Argentina Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 574 Argentina Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 575 Argentina Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 576 UAE Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 577 UAE Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 578 UAE Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 579 UAE Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 580 UAE Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 581 UAE Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 582 UAE Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 583 UAE Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 584 UAE Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 585 UAE Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 586 UAE Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 587 UAE Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 588 UAE Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 589 UAE Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 590 Saudi Arabia Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 591 Saudi Arabia Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 592 Saudi Arabia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 593 Saudi Arabia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 594 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 595 Saudi Arabia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 596 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 597 Saudi Arabia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 598 Saudi Arabia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 599 Saudi Arabia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 600 Saudi Arabia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 601 Saudi Arabia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 602 Saudi Arabia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 603 Saudi Arabia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 604 South Africa Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 605 South Africa Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 606 South Africa Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 607 South Africa Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 608 South Africa Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 609 South Africa Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 610 South Africa Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 611 South Africa Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 612 South Africa Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 613 South Africa Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 614 South Africa Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 615 South Africa Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 616 South Africa Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 617 South Africa Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 618 Nigeria Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 619 Nigeria Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 620 Nigeria Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 621 Nigeria Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 622 Nigeria Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 623 Nigeria Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 624 Nigeria Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 625 Nigeria Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 626 Nigeria Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 627 Nigeria Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 628 Nigeria Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 629 Nigeria Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 630 Nigeria Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 631 Nigeria Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 632 Rest of LAMEA Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 633 Rest of LAMEA Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 634 Rest of LAMEA Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 635 Rest of LAMEA Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 636 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 637 Rest of LAMEA Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 638 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 639 Rest of LAMEA Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 640 Rest of LAMEA Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 641 Rest of LAMEA Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 642 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 643 Rest of LAMEA Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 644 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 645 Rest of LAMEA Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 646 Key information - BioMerieux S.A.
  • TABLE 647 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 648 Key information - Becton, Dickinson and Company
  • TABLE 649 Key Information - Abbott Laboratories
  • TABLE 650 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 651 Key Information - DiaSorin S.p.A.
  • TABLE 652 Key Information - Bruker Corporation
  • TABLE 653 Key Information - Siemens Healthineers AG
  • TABLE 654 Key Information - Danaher Corporation
  • TABLE 655 key information - Quidel Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players
  • FIG 5 Global Sepsis Diagnostics Market Share by Method, 2021
  • FIG 6 Global Sepsis Diagnostics Market Share by Method, 2028
  • FIG 7 Global Sepsis Diagnostics Market by Method, 2018 - 2028, USD Million
  • FIG 8 Global Sepsis Diagnostics Market Share by Test Type, 2021
  • FIG 9 Global Sepsis Diagnostics Market Share by Test Type, 2028
  • FIG 10 Global Sepsis Diagnostics Market by Test Type, 2018 - 2028, USD Million
  • FIG 11 Global Sepsis Diagnostics Market Share by Pathogen, 2021
  • FIG 12 Global Sepsis Diagnostics Market Share by Pathogen, 2028
  • FIG 13 Global Sepsis Diagnostics Market by Pathogen, 2018 - 2028, USD Million
  • FIG 14 Global Sepsis Diagnostics Market Share by Product, 2021
  • FIG 15 Global Sepsis Diagnostics Market Share by Product, 2028
  • FIG 16 Global Sepsis Diagnostics Market by Product, 2018 - 2028, USD Million
  • FIG 17 Global Sepsis Diagnostics Market Share by End-User, 2021
  • FIG 18 Global Sepsis Diagnostics Market Share by End-User, 2028
  • FIG 19 Global Sepsis Diagnostics Market by End-User, 2018 - 2028, USD Million
  • FIG 20 Global Sepsis Diagnostics Market Share by Technology, 2021
  • FIG 21 Global Sepsis Diagnostics Market Share by Technology, 2028
  • FIG 22 Global Sepsis Diagnostics Market by Technology, 2018 - 2028, USD Million
  • FIG 23 Global Sepsis Diagnostics Market Share by Region, 2021
  • FIG 24 Global Sepsis Diagnostics Market Share by Region, 2028
  • FIG 25 Global Sepsis Diagnostics Market by Region, 2018 - 2028, USD Million
  • FIG 26 Recent strategies and developments: Thermo Fisher Scientific, Inc.
  • FIG 27 Swot analysis: thermo fisher scientific, inc.
  • FIG 28 Recent strategies and developments: Bruker Corporation